John Varga, MD; Juha Peltonen, MD, PhD; Jouni Uitto, MD, PhD; Sergio Jimenez, MD
Varga J, Peltonen J, Uitto J, Jimenez S. Development of Diffuse Fasciitis with Eosinophilia during L-Tryptophan Treatment: Demonstration of Elevated Type I Collagen Gene Expression in Affected Tissues: A Clinicopathologic Study of Four Patients. Ann Intern Med. 1990;112:344-351. doi: 10.7326/0003-4819-112-5-344
Download citation file:
Published: Ann Intern Med. 1990;112(5):344-351.
We describe the cases of four women who developed a scleroderma-like syndrome during L-tryptophan treatment for insomnia or tinnitus. The illness was characterized by swelling of the extremities, skin rash, myalgia, and elevation of the peripheral blood eosinophil count, followed by rapidly progressive cutaneous and subcutaneous induration. The histopathologic examination of affected skin showed thickening of the fascia, deep dermal fibrosis, and accumulation of mononuclear cells and abundant eosinophils. The expression of the type I procollagen gene was examined by in-situ hybridizations of affected skin with a human sequence-specific complementary DNA (cDNA). Increased hybridization signals were detected in the deep dermis and fascia, indicating enhanced expression of the collagen gene. The temporal association of L-tryptophan use and the development of a scleroderma-like illness in these four patients suggests a causal relation between L-tryptophan or its metabolites and the stimulation of fibroblast collagen gene expression that results in dermal and fascial fibrosis.
Learn more about subscription options.
Register Now for a free account.
Neurology, Pulmonary/Critical Care, Rheumatology, Scleroderma, Sleep Disorders.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only